Framing Business Uncertainty : Unseen Value in Uncertain Science and Novel Innovation. Think Uncertainty. Think Possibility. Think Opportunity. Think Probability.

Firstly, this book has to be read slowly and requires patience to properly ferment the brain. Thinking & counter-confirmation are far more important than reading. "Framing Business Uncertainty" offers practical frameworks and tools to help businesses/Investors to thrive in an uncertain world. One of the key strengths of the book lies in its deep understanding of uncertainty. Instead of viewing it as solely a threat to be mitigated, the author argues that uncertainty can be a source of innovation and competitive advantage if managed effectively. (Uncertainty --> optionality --> antifragility) Even though the book is focused on Science and Novel innovation, but the Framework and principles discussed in the book are applicable across businesses as well as in real life. Throughout the book, the author focuses on a real-life case studies, real-world examples, and practical insights to illustrate his points. Here is what I got so far: • Uncertainty Perspective and drivers, Uncertainty balancers, probabilistic thinking • Anti-fragility thinking in a chaotic and fragile world. • Don't be Turkey (game of prediction), Be Inverse Turkey (antifragile) • Idea of possibility quotient to differentiate between fragile vs anti-fragile business • CDMO Science as a service (SAAS) model - win-win partnership of collaboration. Key success factors • Key elements of 'Fait sur measure' to access CDMO SAAS partner competitive advantage (entry & exit barriers) • Molecule economics & supply side economics • Valuation framework Overall, this book is a must-read for anyone seeking to thrive in today's uncertain world. It equips readers with the mindset and tools necessary to turn ambiguity into advantage. Thank you Mr Sajal Kapoor for writing this book and sharing your experiences and wisdom gained over decades. Learnings from this book really going to help me to think differently in my investing journey.

Its a whole new world of pharmaceuticals/ cdmo. Never saw this sector via such lens. This book makes you think, it gives you food for thought and so many things. I have been reading again and again. Its a book to hold onto forever and ever.

TL;DR Capture low priced options (Downside is limited, upside is unlimited) while building your business out as an owner, or, in your stock investment). In the life sciences space, CDMO has these characteristics… collaborate with innovators on different molecules; molecules fail - you hv invaluable learnings (and got paid for it); molecule succeeds - cash flow bonanza. Failure in this business under the right management makes you stronger, doesn’t kill you. Hence antifragile… something that grows stronger with stress. Combine this with a pipeline of molecules under various stages of development - anti fragile business, with low priced options. An asymmetric bet. ——————————— The ‘Incerto series’ (taleb’s 5 books) sets up the background role of luck, uncertainty, probability, assymetric nature of risks and rewards of investment decisions. Where this book scores is in using this framework to explain the CDMO businesses of various companies in India. Which of them show anti fragile properties and which are extremely fragile. This is the foundation. Every other analysis (fundamental or technical) is the super structure and dependant on the strength of the foundation. Helped me to look at a few of my core holdings in a new light… eg, Suven Lifesciences, low priced option, but also a fragile business. Where this book does not score (for me) is in expending too many pages setting up the background. Those that have read incerto, could feel the setup tedious and repetitive, and would want the author to ‘get on with it’. For those that have not read incerto, Taleb’s risk analysis language can be intimidating… Extremistan, Inverse turkey, Lindy, via negativa et al. Many would lose interest in the detailed background = negative reviews of boring book... even those who have come to learn about Indian pharma and not just stock tips. Very few will be in the happy intersection of this Venn diagram (not read taleb + interested in his thought process). For me - Taleb the author >> Twitter Taleb Twitter unseenvalue >> Author S Kapoor

Before I write on the book, it's important to know about Mr. Sajal Kapoor Sir and why this book demands to be a must-read by Investors Sajal Sir has a rich experience of more than 2.5 decades in the pharma field and the Investing Field On Twitter, he makes sure to simplify the Entire healthcare space and other complex subjects for his students/followers (including me) I was fortunate enough to meet him in Mumbai a few months back and what a gem of a person he is! He made me feel so big in front of others (I read a quote that says - A big person isn't someone who has big cars, a lot of money, and power, It is a person who makes the other person feel great) Do pick up the book, I strongly recommend it - A lot of concepts are explained with rich examples that no other book will be able to give you! Rich Experiences make for great books and this is what makes the book stand out - The writer's Rich Experience across the Globe!

Following him since 2021 after listening him in a SOIC webinar, after that listened his every podcast / webinar and everytime he opened a new door of knowledge, thinking ahead of curve. This book is a wealth of knowledge not only for Pharma and chemical but for overall investing framework. What I more like is his philanthropic approach / work. Most of his wisdom is available on uTube and Twitter for free, if someone is truly interested to learn. Everytime I re-read the chapter of this book, I come to learn something new. A true masterpiece!!

1. the book is revolved around Taleb and there are instances where the reader feels more attached towards taleb than the author, considering that the book was to read snippets of authors life and experience around his uncertainty 2. Avid readers who follow the author could easily connect as they know the dots, but for a first time reader not knowing anything about sajal kapoor and his framework on twitter would be somewhat looking for clues on every lose end. 3. Every twitter follower might read your book, but every book reader might not be your follower on twitter. 4. Technical word explanations like molecules names and models of uncertainty could be simplified more so that a new reader could take it as a learning and not as a challenge. The key word is some and not all 5. Authors real life, childhood examples could’ve helped me connect more to the author, it shouldn’t feel like you’re explaining taleb to me. Rather it should be you explaining your life using talebs model. 6. When is the next book coming out :)

In these 300 odd page, Sajal Kapoor has shared his years of learning about the life sciences / CRDMO sector. It will help accelerate the learning process for someone who is just starting to learn about the sector. It certainly stands out for its industry specific knowledge, and perhaps un-matched to any other that i have come across. I also liked the author's very candid sharing of his own investment journey which did strike a chord with me, personally. Especially Pg 303 - "It's always the extremes in markets that challenge our core behaviour. To win in the long run, you must stay in the game and sustain the extremes. It's completely pointless to time the bottom or the top of a business cycle, let alone the overall market. Time in the market does the heavy lifting for you."

The book is good, it gives a framework for surviving and growing capital in equity. However the printing quality is bad. The pages start coming out as you progress.

I have thoroughly enjoyed Mr. Sajal Kapoor's debut book, finding it to be a valuable resource for gaining insights into various aspects of business, particularly in the context of the uncertain pharmaceutical industry. The clarity and enthusiasm with which Mr. Kapoor writes, along with his eclectic knowledge, have left a strong impression on me. His book is essential reading for individuals involved in equities and seeking to expand their understanding of business dynamics. I have purchased additional copies of the book to gift to my friends in the USA underscores the value place on the insights it offers. Mr. Kapoor's work has resonated with me and has the potential to make a significant impact on others as well. Excellent Work Dear Sajal, wishing you continued success in all endeavors.

Tasteful blend of science, business finance, history with tadka of Cricket. Fundamental concepts explained in the book are borderless and apply in any market. This timeless classic brings life lessons to forth with honest confessions and wisdom gained over decades of reflection.

Overall, it was an enjoyable read. It teaches us about fragility and how not to invest, and it encourages long-term thinking in a world where unexpected occurrences might hurt us. Nassim Tabel's INCERTO has a strong influence on his thinking. He simplified many concepts from Nassim's books. In his book, Peter Thiel also compared software startups to low-risk discovery and investment processes in healthcare and innovation.

Framing Business Uncertainty” is a thought-provoking exploration of the role of uncertainty in business and innovation. The author, Mr. Kapoor, delves into the concept of uncertainty not just as a challenge to overcome, but as a potential catalyst for growth and competitive advantage, with a focus on practical frameworks, the book encourages a shift from traditional probabilistic thinking to embracing anti-fragility, where businesses can not only withstand chaos but also benefit from it. highly recommended for serious investors.